Regulatory Authority | National Institute of Pharmacy and Nutrition |
---|---|
Regulatory Authority Website Link | Click Here |
Device Classification | I, IIa, IIb and III |
Medical Device Regulations | EUMDR-2017/745 | Click Here |
IVD Classification | A,B,C,D |
In Vitro Diagnostics Regulations | (EU) 2017/745 | Click Here |
Registration Process | Device Registration | Click Here |
Registration Timeline | For Class I, it is 1 to 2 months and for other classes, it depends on the notified body and type of product |
Requirement of Authorized Representative | Yes |
Language Requirement | Labels must be in Hungarian Language |
Clinical Trials Information |
OGYEI can grant permission for the use of medical devices bearing or not yet bearing the CE marking in clinical examination if performed in Hungary. In general, clinical investigations of investigational medical devices require two types of assessment, from a National Competent Authority for medical devices (NNGYK) and from a relevant Research Ethics Committee (ETT-TUKEB), prior to beginning the study. | Click Here |
Database | EUDAMEDOGYEI | Click Here |
Declaration of Conformity |
Article 19: EU declaration of conformity
The EU declaration of conformity shall state that the requirements specified in this Regulation have been fulfilled in relation to the device that is covered. |
Certificate of Free Sale |
OGYEI issues Free Sales certificate to manufacturers of medical devices who are headquartered in Hungary and have registered as manufacturers in Hungary. |
Post Market Surveillance |
Event of death or an unanticipated serious deterioration in a person's state of health- Immidiately, but not later than 10 days after the date on which the manufacturer becomes aware of the serious incident. Serious public health threat- immediately, and not later than 2 days after the manufacturer becomes aware of that threat. |
Reportable Incidents |
The European Commission has published guidance on the reporting of serious adverse events (SAE) and device deficiency (MDCG 2020 10/1 Safety Reporting in clinical investigations of medical devices under the Regulation (EU) 2017/745) and the NNGYK expects all sponsors to follow this guidance. |
Adverse Event Reporting Form | Download |
Advertising and Promotions |
There are two possibilities during the advertising activity:
|
Additional Information | A distributors, importers (authorised representatives if they market medical devices) are required to register on the national OGYEI |